The life sciences technology development company RainDance Technologies has raised $16.5 million from new investors GE Ventures and Northgate Capital as it looks to make its liquid biopsy technology available commercially. To date, RainDance has raised well over $100 million in equity and debt to back its vision and develop its technology, which is currently being used as a research tool for… Read More
No comments:
Post a Comment